Loss of neuronal integrity: a cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage

  • Tohru Shiga
  • Katsunori Ikoma
  • Chietsugu Katoh
  • Hirotaka Isoyama
  • Tetsuaki Matsuyama
  • Yuji Kuge
  • Hiroyuki Kageyama
  • Tomoya Kohno
  • Satoshi Terae
  • Nagara Tamaki
Original article



Traumatic brain injury (TBI) causes brain dysfunction in many patients. However, some patients have severe brain dysfunction but display no abnormalities on magnetic resonance imaging (MRI). There have been some reports of hypometabolism even in such patients. The purpose of this study was to investigate the relationship between metabolic abnormality and loss of neuronal integrity in TBI patients with some symptoms but without MRI abnormalities.


The study population comprised ten patients with TBI and ten normal volunteers. All of the patients were examined at least 1 year after the injury. 15O-labelled gas PET and [11C]flumazenil (FMZ) positron emission tomography (PET) were carried out. The cerebral metabolic rate of oxygen (CMRO2) and binding potential (BP) images of FMZ were calculated. Axial T2WI, T2*WI and FLAIR images were obtained. Coronal images were added in some cases.


All of the patients had normal MRI findings, and all showed areas with abnormally low CMRO2. Low uptake on BP images was observed in six patients (60%). No lesions that showed low uptake on BP images were without low CMRO2. On the other hand, there were 14 lesions with low CMRO2 but without BP abnormalities.


These results indicate that there are metabolic abnormalities in TBI patients with some symptoms after brain injury but without abnormalities on MRI. Some of the hypometabolic lesions showed low BP, indicating a loss of neuronal integrity. Thus, FMZ PET may have potential to distinguish hypometabolism caused by neuronal loss from that caused by other factors.


Brain imaging PET MRI Flumazenil Traumatic brain injury 


  1. 1.
    Thurman D, Guerrero J. Trends in hospitalization associated with traumatic brain injury. JAMA 1999;282(10):954–7CrossRefPubMedGoogle Scholar
  2. 2.
    Sander AM, Kreutzer JS, Rosenthal M, Delmonico R, Young ME. A multicenter longitudinal investigation of return to work and community integration following traumatic brain injury. J Head Trauma Rehabil 1996;11:70–84CrossRefGoogle Scholar
  3. 3.
    Maziere M, Prenant C, Sastre J, Crouzel M, Comar D, Hantraye P, et al. 11C-R[O-15]-1788 et 11C-flunitrazepam, deux coordinats pour l’etude par tomographie par positons des sites de liaison des benzodiazepines. C R Seances Acad Sci III 1983;296(18):871–6PubMedGoogle Scholar
  4. 4.
    Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA. Changes in gamma-aminobutyric and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 1992;77:209–16PubMedCrossRefGoogle Scholar
  5. 5.
    Wolf HK, Roos D, Blumcke I, Pietsch T, Wiestler OD. Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol (Berl) 1996;91:376–84CrossRefGoogle Scholar
  6. 6.
    Rudolf J, Sobesky J, Grond M, Heiss WD. Identification by positron emission tomography of neuronal loss in acute vegetative state. Lancet 2000;355(9198):115–6CrossRefPubMedGoogle Scholar
  7. 7.
    Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke 1997;28(1):124–32PubMedGoogle Scholar
  8. 8.
    Heiss WD, Graf R, Wienhard K. Relevance of experimental ischemia in cats for stroke management: a comparative reevaluation. Cerebrovasc Dis 2001;11(2):73–81CrossRefPubMedGoogle Scholar
  9. 9.
    Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001;124(Pt 1):20–9CrossRefPubMedGoogle Scholar
  10. 10.
    Heiss WD, Kracht L, Grond M, Rudolf J, Bauer B, Wienhard K, et al. Early [11C]flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 2000;31(2):366–9PubMedGoogle Scholar
  11. 11.
    Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, et al. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998;29(2):454–61PubMedGoogle Scholar
  12. 12.
    Kuroda S, Shiga T, Ishikawa T, Houkin K, Narita T, Katoh C, et al. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases. J Nucl Med 2004;45(6):943–9PubMedGoogle Scholar
  13. 13.
    Goshen E, Zwas ST, Shahar E, Tadmor R. The role of 99Tcm-HMPAO brain SPET in paediatric traumatic brain injury. Nucl Med Commun 1996;17(5):418–22PubMedCrossRefGoogle Scholar
  14. 14.
    Newton MR, Greenwood RJ, Britton KE, Charlesworth M, Nimmon CC, Carroll MJ, et al. A study comparing SPECT with CT and MRI after closed head injury. J Neurol Neurosurg Psychiatry 1992;55(2):92–4PubMedCrossRefGoogle Scholar
  15. 15.
    Mattioli F, Grassi F, Perani D, Cappa SF, Miozzo A, Fazio F. Persistent post-traumatic retrograde amnesia: a neuropsychological and (18F)FDG PET study. Cortex 1996;32(1):121–9PubMedGoogle Scholar
  16. 16.
    Adriaan AL, Susan PH. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153–8CrossRefPubMedGoogle Scholar
  17. 17.
    Shiga T, Morita K, Takano A, Katoh C, Nakamura F, Tsukamoto E, et al. Clinical advantages of interictal SPECT coregistered to magnetic resonance imaging in patients with epilepsy. Clin Nucl Med 2001;26(4):334–9CrossRefPubMedGoogle Scholar
  18. 18.
    Wechsler D. Manual for the Wechsler adult intelligence scale-revised (WAIS-R). San Antonio, TX: The Psychological Corporation; 1981Google Scholar
  19. 19.
    Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98CrossRefPubMedGoogle Scholar
  20. 20.
    Muller V, Saur D, Klutmann S, Weiller C, Rother J, Clausen M. Experience with 123I-iomazenil SPECT in acute cerebral infarction. Nucl Med Commun 2002;23(12):1191–6CrossRefPubMedGoogle Scholar
  21. 21.
    Ohyama M, Senda M, Ishiwata K, Kitamura S, Mishina M, Ishii K, et al. Preserved benzodiazepine receptors in Alzheimer’s disease measured with [C-11] flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 1999;13(5):309–15PubMedGoogle Scholar
  22. 22.
    Ryvlin P, Bouvard S, Le Bars D, Mauguiere F. Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology 1999;53(8):1882–5PubMedGoogle Scholar
  23. 23.
    Juhasz C, Nagy F, Muzik O, Watson C, Shah J, Chugani HT. [11C]Flumazenil PET in patients with epilepsy with dual pathology. Epilepsia 1999;40(5):566–74PubMedGoogle Scholar
  24. 24.
    Kaji T, Kuge Y, Yokota C, Tagaya M, Inoue H, Shiga T, et al. Characterisation of [123I]iomazenil distribution in a rat model of focal cerebral ischaemia in relation to histopathological findings. Eur J Nucl Med Mol Imaging 2004;31(1):64–70CrossRefPubMedGoogle Scholar
  25. 25.
    Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, Seike Y, et al. [Evaluation of 123I-iomazenil SPECT in patients with ischemic cerebrovascular disease: comparative study with 123I-IMP SPECT]. Kaku Igaku 1996;33(6):587–97PubMedGoogle Scholar
  26. 26.
    Tsuchida T, Yonekura Y, Sadato N, Takahashi N, Yamamoto K, Ishii Y. Prediction of improvement of cerebral perfusion with I-123 iomazenil SPECT. Ann Nucl Med 1999;13(4):265–8PubMedCrossRefGoogle Scholar
  27. 27.
    Shiozaki T, Akai H, Taneda M, Hayakata T, Aoki M, Oda J, et al. Delayed hemispheric neuronal loss in severely head-injured patients. J Neurotrauma 2001;18(7):665–74CrossRefPubMedGoogle Scholar
  28. 28.
    Gentry LR, Godersky JC, Thompson B. MR imaging of head trauma: review of the distribution and radiopathologic features of traumatic lesions. AJR Am J Roentgenol 1988;150(3):663–72PubMedGoogle Scholar
  29. 29.
    Adams JH. Pathology of nonmissile head injury. Neuroimaging Clin North Am 1991;397–410Google Scholar
  30. 30.
    Raghupathi R, Conti AC, Graham DI, Krajewski S, Reed JC, Grady MS, et al. Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity. Neuroscience 2002;110(4):605–16CrossRefPubMedGoogle Scholar
  31. 31.
    Son BC, Park CK, Choi BG, Kim EN, Choe BY, Lee KS, et al. Metabolic changes in pericontusional oedematous areas in mild head injury evaluated by 1H MRS. Acta Neurochir Suppl (Wien) 2000;76:13–6Google Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Tohru Shiga
    • 1
  • Katsunori Ikoma
    • 2
  • Chietsugu Katoh
    • 3
  • Hirotaka Isoyama
    • 2
  • Tetsuaki Matsuyama
    • 1
  • Yuji Kuge
    • 3
  • Hiroyuki Kageyama
    • 1
  • Tomoya Kohno
    • 1
  • Satoshi Terae
    • 4
  • Nagara Tamaki
    • 1
  1. 1.Department of Nuclear MedicineHokkaido University School of MedicineKitaku SapporoJapan
  2. 2.Department of RehabilitationHokkaido University,SapporoJapan
  3. 3.Department of Tracer kineticsHokkaido University,SapporoJapan
  4. 4.Department of RadiologyHokkaido University,SapporoJapan

Personalised recommendations